title: Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix.
abstract: We studied the contribution of matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) to the beneficial effects of preconditioning (PC) in reduced-size orthotopic liver transplantation (ROLT). We also examined the role of c-Jun N-terminal kinase (JNK) and whether it regulates MMP2 in these conditions. Animals were subjected to ROLT with or without PC and pharmacological modulation, and liver tissue samples were then analyzed. We found that MMP2, but notMMP9, is involved in the beneficial effects of PC in ROLT. MMP2 reduced hepatic injury and enhanced liver regeneration. Moreover, inhibition of MMP2 in PC reduced animal survival after transplantation. JNK inhibition in the PC group decreased hepatic injury and enhanced liver regeneration. Furthermore, JNK upregulated MMP2 in PC. In addition, we showed that Tissue inhibitors of matrix metalloproteinases 2 (TIMP2) was also upregulated in PC and that JNK modulation also altered its levels in ROLT and PC. Our results open up new possibilities for therapeutic treatments to reduce I/R injury and increase liver regeneration after ROLT, which are the main limitations in living-donor transplantation.
authors.affiliation: Experimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas, Barcelona, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Padrissa-Altés
authors.forename: M A
authors.initials: MA
authors.lastname: Zaouali
authors.forename: R
authors.initials: R
authors.lastname: Franco-Gou
authors.forename: R
authors.initials: R
authors.lastname: Bartrons
authors.forename: O
authors.initials: O
authors.lastname: Boillot
authors.forename: A
authors.initials: A
authors.lastname: Rimola
authors.forename: V
authors.initials: V
authors.lastname: Arroyo
authors.forename: J
authors.initials: J
authors.lastname: Rodés
authors.forename: C
authors.initials: C
authors.lastname: Peralta
authors.forename: J
authors.initials: J
authors.lastname: Roselló-Catafau
mesh_terms: D000818:Animals; D048031:JNK Mitogen-Activated Protein Kinases; D008099:Liver / Q000033:anatomy & histology*; D008115:Liver Regeneration / Q000187:drug effects; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000494:pharmacology; D020780:Matrix Metalloproteinase 9 / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000494:pharmacology
chemical_list: D019716:Tissue Inhibitor of Metalloproteinase-2; D048031:JNK Mitogen-Activated Protein Kinases; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9